摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5,7-dibenzyloxy-2-(2,2-diphenylbenzo[d][1,3]dioxol-5-yl)-3-β-D-glucosyl-4H-chromen-4-one | 477244-20-5

中文名称
——
中文别名
——
英文名称
5,7-dibenzyloxy-2-(2,2-diphenylbenzo[d][1,3]dioxol-5-yl)-3-β-D-glucosyl-4H-chromen-4-one
英文别名
2-(2,2-diphenylbenzo[1,3]dioxol-5-yl)-3-β-D-glucopyranosyloxy-5,7-bisbenzyloxy-4H-chromen-4-one;5,7-dibenzyloxy-2-(3',4'-dihydroxyphenyl)-3-β-D-glucosyl-4H-chomen-4-one;2-(2,2-diphenyl-1,3-benzodioxol-5-yl)-5,7-bis(phenylmethoxy)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one
5,7-dibenzyloxy-2-(2,2-diphenylbenzo[d][1,3]dioxol-5-yl)-3-β-D-glucosyl-4H-chromen-4-one化学式
CAS
477244-20-5
化学式
C48H40O12
mdl
——
分子量
808.838
InChiKey
HTCUNQJYCRZQMM-RLYYWKKQSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    7
  • 重原子数:
    60
  • 可旋转键数:
    12
  • 环数:
    9.0
  • sp3杂化的碳原子比例:
    0.19
  • 拓扑面积:
    163
  • 氢给体数:
    4
  • 氢受体数:
    12

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Regio- and stereoselective synthesis of the major metabolite of quercetin, quercetin-3-O-β-d-glucuronide
    作者:Mohamed Bouktaib、Aziz Atmani、Christian Rolando
    DOI:10.1016/s0040-4039(02)01264-9
    日期:2002.8
    Protected quercetin was first transformed selectively in its 3-O-beta-D-glucoside. Further protection of the remaining phenolic hydroxyl group allows a clean oxidation of the glucoside by TEMPO/NaOCl/NaBr under phase transfer conditions into the corresponding glucuronide which was cleanly deprotected to quercetin-3-O-beta-D-glucuronide. (C) 2002 Elsevier Science Ltd. All rights reserved.
  • Design, synthesis, and biological evaluation of a novel series of quercetin diacylglucosides as potent anti-MRSA and anti-VRE agents
    作者:Abugafar M.L. Hossion、Nao Otsuka、Rafiya K. Kandahary、Tomofusa Tsuchiya、Wakano Ogawa、Akimasa Iwado、Yoshito Zamami、Kenji Sasaki
    DOI:10.1016/j.bmcl.2010.02.060
    日期:2010.9
    A series of novel quercetin diacylglucosides were designed and first synthesized by Steglich esterification on the basis of MRSA strains inhibiting natural compound A. The in vitro inhibition of different multidrug resistant bacterial strains and Escherichia coli DNA gyrase B was investigated. In the series, compound 10h was up to 128-fold more potent against vancomycin-resistant enterococci and more effective than A, which represents a promising new candidate as a potent anti-MRSA and anti-VRE agent. (C) 2010 Published by Elsevier Ltd.
查看更多